Multimodality approach for locally advanced lung cancer: when is surgery most beneficial?
Surgical resection, particularly when achieving negative margins (R0) inpatients with N0 disease, is critical for improving survival in patients with Stage IIINSCLC. Multimodal strategies can enhance these benefits further. However, challengesrelated to healthcare access in resource-limited settings highlight the need for customizedtreatment protocols and broader access to advanced medical therapies.
Authors
- Riad Abdeljalil
- Sameer Yaser
- Riad Abdel Jalil (ORCID: https://orcid.org/0000-0001-8018-6148)
- Husam Abu Jazar
- Taher Abu Hejleh (ORCID: https://orcid.org/0000-0002-2476-4879)
- Jamal K. Khader
- Hussam Haddad
- Ahed Al-odwan
- Leen Osama Nemrawi
- Sakhr Alshwayyat
- Kamal Alrabi
- Anoud Al-Nsour
Institutions
- Applied Science Private University (JO)
- King Hussein Cancer Center (JO)
- Kern Medical Center (US)
Publication Details
- Journal
- Journal of Cardiothoracic Surgery
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1186/s13019-025-03752-9
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00